Tesamorelin, marketed under the brand name Egrifta, is a prescription peptide therapy best known for its ability to reduce visceral fat—the deep abdominal fat linked to metabolic disease. Originally approved for people living with HIV, Tesamorelin has gained broader attention for its effects on growth hormone release, body composition, and metabolic health.
This guide breaks down what Tesamorelin is, how it works, its benefits, side effects, and who it may be appropriate for, in a clear, SEO-friendly format.
What Is Tesamorelin (Egrifta)?
Tesamorelin is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH). Rather than supplying growth hormone directly, it stimulates your pituitary gland to release your own natural growth hormone in a regulated, pulsatile manner.
Egrifta is FDA-approved specifically to treat HIV-associated lipodystrophy, a condition characterized by excessive accumulation of visceral abdominal fat.
How Tesamorelin Works
Tesamorelin binds to GHRH receptors in the pituitary gland, triggering the release of endogenous growth hormone (GH). This rise in GH leads to increased production of IGF-1 (Insulin-Like Growth Factor-1), which plays a key role in:
- Fat metabolism
- Muscle maintenance
- Cellular repair
- Insulin sensitivity
Unlike direct HGH injections, Tesamorelin works upstream, allowing the body’s natural feedback loops to remain intact.
Key Benefits of Tesamorelin
1. Reduction of Visceral Abdominal Fat
Tesamorelin is clinically proven to significantly reduce visceral adipose tissue (VAT)—the dangerous fat surrounding internal organs. This is its primary FDA-approved benefit.
2. Improved Body Composition
Users often report:
- Leaner waistline
- Improved fat-to-muscle ratio
- Better overall physique
Notably, Tesamorelin targets deep fat, not just subcutaneous fat.
3. Supports Metabolic Health
By reducing visceral fat, Tesamorelin may contribute to:
- Improved lipid profiles
- Better insulin sensitivity
- Lower cardiometabolic risk
4. Preserves Natural Growth Hormone Regulation
Because Tesamorelin stimulates endogenous GH release rather than replacing it, the risk of GH shutdown is significantly lower compared to exogenous HGH.
5. Potential Cognitive and Energy Benefits
Some users report secondary benefits such as:
- Increased energy
- Improved focus
- Better sleep quality
(These effects are not FDA-approved indications but are commonly reported.)
Tesamorelin vs HGH: What’s the Difference?
| Feature | Tesamorelin | HGH |
| Mechanism | Stimulates natural GH | Direct hormone replacement |
| GH Regulation | Preserves feedback loop | Can suppress natural GH |
| FDA Approval | Yes (for HIV lipodystrophy) | Yes (specific deficiencies only) |
| Side Effect Risk | Lower | Higher (edema, insulin resistance) |
Dosage and Administration
- Typical dose: 2 mg once daily
- Route: Subcutaneous injection
- Timing: Often administered at night
Tesamorelin must be reconstituted prior to injection and stored properly. Always follow prescribing instructions from a licensed medical provider.
Side Effects and Safety
Common Side Effects
- Injection site irritation
- Mild swelling or redness
- Joint or muscle discomfort
Less Common but Serious
- Increased IGF-1 levels
- Fluid retention
- Glucose intolerance in predisposed individuals
Tesamorelin is not recommended for individuals with:
- Active malignancy
- Pituitary disorders
- Known hypersensitivity to the drug
Who Is Tesamorelin Best For?
Tesamorelin may be appropriate for:
- Individuals with HIV-associated visceral fat accumulation
- Patients seeking medically supervised visceral fat reduction
- Those who cannot tolerate or should avoid direct HGH therapy
It is not a general weight-loss drug and should only be used under medical supervision.
Is Tesamorelin Legal and Prescription-Only?
Yes. Tesamorelin (Egrifta) is legal but prescription-only in the United States. Any product marketed as Tesamorelin without a prescription should be approached with caution.
Final Thoughts: Is Tesamorelin Worth It?
Tesamorelin stands out as a targeted, science-backed therapy for reducing visceral fat while maintaining the body’s natural hormone regulation. For qualifying patients, especially those with HIV-related lipodystrophy, it can be a powerful and clinically validated solution.
If you’re considering Tesamorelin for body composition or metabolic health, consult a licensed healthcare provider to determine if it’s appropriate for your specific needs.